ピラルビシン
Wikipedia preview
出典(authority):フリー百科事典『ウィキペディア(Wikipedia)』「2012/04/06 11:11:37」(JST)
[Wiki en表示]
Pirarubicin
|
Systematic (IUPAC) name |
(3S)-3-glycoloyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-4-O-[(2R)-tetrahydro-2H-pyran-2-yl]-α-L-lyxo-hexopyranoside |
Clinical data |
AHFS/Drugs.com |
International Drug Names |
Pregnancy cat. |
? |
Legal status |
℞ Prescription only |
Identifiers |
CAS number |
72496-41-4 Y |
ATC code |
L01DB08 |
PubChem |
CID 3033521 |
UNII |
D58G680W0G N |
KEGG |
D01885 Y |
ChEMBL |
CHEMBL40848 N |
Synonyms |
(9S)-7-[(2R,4S,5S,6S)-4-amino-6-methyl-5-[(2R)-oxan-2-yl]oxyoxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione |
Chemical data |
Formula |
C32H37NO12 |
Mol. mass |
627.63 g/mol |
SMILES |
eMolecules & PubChem |
N (what is this?) (verify)
|
Pirarubicin (INN) is an anthracycline drug.
Intracellular chemotherapeutic agents / antineoplastic agents (L01)
|
|
SPs/MIs
(M phase) |
Block microtubule assembly
|
- Vinca alkaloids (Vinblastine
- Vincristine
- Vinflunine
- Vindesine
- Vinorelbine)
|
|
Block microtubule disassembly
|
- Taxanes (Cabazitaxel
- Docetaxel
- Larotaxel
- Ortataxel
- Paclitaxel
- Tesetaxel)
- Epothilones (Ixabepilone)
|
|
|
DNA replication
inhibitor |
DNA precursors/
antimetabolites
(S phase)
|
Folic acid
|
- Dihydrofolate reductase inhibitor (Aminopterin
- Methotrexate
- Pemetrexed
- Pralatrexate)
- Thymidylate synthase inhibitor (Raltitrexed
- Pemetrexed)
|
|
Purine
|
- Adenosine deaminase inhibitor (Pentostatin)
- Halogenated/ribonucleotide reductase inhibitors (Cladribine
- Clofarabine
- Fludarabine)
- Thiopurine (Thioguanine
- Mercaptopurine)
|
|
Pyrimidine
|
- Thymidylate synthase inhibitor (Fluorouracil
- Capecitabine
- Tegafur
- Carmofur
- Floxuridine)
- DNA polymerase inhibitor (Cytarabine)
- Ribonucleotide reductase inhibitor (Gemcitabine)
- Hypomethylating agent (Azacitidine
- Decitabine)
|
|
Deoxyribonucleotide
|
- Ribonucleotide reductase inhibitor (Hydroxycarbamide)
|
|
|
Topoisomerase inhibitors
(S phase)
|
I
|
- Camptotheca (Camptothecin
- Topotecan
- Irinotecan
- Rubitecan
- Belotecan)
|
|
II
|
- Podophyllum (Etoposide
- Teniposide)
|
|
II+Intercalation
|
- Anthracyclines (Aclarubicin
- Daunorubicin
- Doxorubicin
- Epirubicin
- Idarubicin
- Amrubicin
- Pirarubicin
- Valrubicin
- Zorubicin)
- Anthracenediones (Mitoxantrone
- Pixantrone)
|
|
|
Crosslinking of DNA
(CCNS)
|
Alkylating
|
- Nitrogen mustards: Mechlorethamine
- Cyclophosphamide (Ifosfamide
- Trofosfamide)
- Chlorambucil (Melphalan
- Prednimustine)
- Bendamustine
- Uramustine
- Estramustine
- Nitrosoureas: Carmustine
- Lomustine (Semustine)
- Fotemustine
- Nimustine
- Ranimustine
- Streptozocin
- Alkyl sulfonates: Busulfan (Mannosulfan
- Treosulfan)
- Aziridines: Carboquone
- ThioTEPA
- Triaziquone
- Triethylenemelamine
|
|
Alkylating-like
|
- Platinum (Carboplatin
- Cisplatin
- Nedaplatin
- Oxaliplatin
- Triplatin tetranitrate
- Satraplatin)
|
|
Nonclassical
|
- Hydrazines (Procarbazine)
- Triazenes (Dacarbazine
- Temozolomide)
- Altretamine
- Mitobronitol
|
|
Intercalation
|
- Streptomyces (Actinomycin
- Bleomycin
- Pingyangmycin
- Mitomycin
- Plicamycin)
|
|
|
|
Photosensitizers/PDT |
- Aminolevulinic acid / Methyl aminolevulinate
- Efaproxiral
- Porphyrin derivatives (Porfimer sodium
- Talaporfin
- Temoporfin
- Verteporfin)
|
|
Other |
Enzyme inhibitors
|
- FI (Tipifarnib)
- CDK inhibitors (Alvocidib
- Seliciclib)
- PrI (Bortezomib)
- PhI (Anagrelide)
- IMPDI (Tiazofurine)
- LI (Masoprocol)
- PARP inhibitor (Olaparib)
- HDAC (Panobinostat
- Vorinostat
- Romidepsin)
|
|
Receptor antagonists
|
- ERA (Atrasentan)
- Retinoid X receptor (Bexarotene)
- Sex steroid (Testolactone)
|
|
Other/ungrouped
|
- Amsacrine
- Trabectedin
- Retinoids (Alitretinoin
- Tretinoin)
- Arsenic trioxide
- Asparagine depleters (Asparaginase/Pegaspargase)
- Celecoxib
- Demecolcine
- Elesclomol
- Elsamitrucin
- Etoglucid
- Lonidamine
- HAMLET (human alpha-lactalbumin made lethal to tumor cells)
- Lucanthone
- Mitoguazone
- Mitotane
- Oblimersen
- Omacetaxine mepesuccinate
- mTOR inhibitors (Everolimus
- Temsirolimus)
|
|
|
|
|
UpToDate Contents
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
- 1. 筋層非浸潤性膀胱癌の治療 treatment of non muscle invasive bladder cancer
English Journal
- Prospective Randomized Phase II Trial of a Single Early Intravesical Instillation of Pirarubicin (THP) in the Prevention of Bladder Recurrence After Nephroureterectomy for Upper Urinary Tract Urothelial Carcinoma: The THP Monotherapy Study Group Trial.
- Ito A, Shintaku I, Satoh M, Ioritani N, Aizawa M, Tochigi T, Kawamura S, Aoki H, Numata I, Takeda A, Namiki S, Namima T, Ikeda Y, Kambe K, Kyan A, Ueno S, Orikasa K, Katoh S, Adachi H, Tokuyama S, Ishidoya S, Yamaguchi T, Arai Y.SourceAkihiro Ito, Ichiro Shintaku, Kazuhiko Orikasa, Shigeto Ishidoya, Takuhiro Yamaguchi, and Yoichi Arai, Tohoku University Graduate School of Medicine; Naomasa Ioritani and Masataka Aizawa, Sendai Shakai Hoken Hospital; Takashige Namima and Yoshihiro Ikeda, Tohoku Rosai Hospital, Sendai; Makoto Satoh, Sen-en General Hospital, Tagajo; Tatsuo Tochigi, Sadafumi Kawamura, and Hiroshi Aoki, Miyagi Cancer Center, Natori; Isao Numata, Atsushi Takeda, and Shunichi Namiki, Osaki Citizen Hospital, Osaki; Koichi Kambe, Senseki Hospital, Higashimatsushima; Atsushi Kyan, Shirakawa Kosei General Hospital, Shirakawa; Seiji Ueno, Kesennuma City Hospital, Kesennuma; Shinnosuke Katoh, Ogachi Central Hospital, Yuzawa; Hisanobu Adachi, Iwate Prefectural Iwai Hospital, Ichinoseki; and Satoru Tokuyama, Iwaki Kyoritsu General Hospital, Iwaki, Japan.
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology.J Clin Oncol.2013 Mar 4. [Epub ahead of print]
- PURPOSEWe evaluated the efficacy of a single early intravesical instillation of pirarubicin (THP) in the prevention of bladder recurrence after nephroureterectomy for upper urinary tract urothelial carcinoma (UUT-UC).Patients And methodsFrom December 2005 to November 2008, 77 patients clinically dia
- PMID 23460707
- Clinical importance of human herpes virus-8 and human immunodeficiency virus infection in primary effusion lymphoma.
- Kumode T, Ohyama Y, Kawauchi M, Yamaguchi T, Miyatake JI, Hoshida Y, Tatsumi Y, Matsumura I, Maeda Y.SourceDepartment of Hematology.
- Leukemia & lymphoma.Leuk Lymphoma.2013 Jan 24. [Epub ahead of print]
- Primary effusion lymphoma (PEL) is a rare type of non-Hodgkin lymphoma that usually develops in immunosuppressed patients infected with human herpes virus-8 (HHV-8) in conjunction with human immunodeficiency virus (HIV) infection. However, there are several reports of HHV-8-related HIV-negative case
- PMID 23278643
- New structure-activity relationship studies in a series of N,N-bis(cyclohexanol)amine aryl esters as potent reversers of P-glycoprotein-mediated multidrug resistance (MDR).
- Orlandi F, Coronnello M, Bellucci C, Dei S, Guandalini L, Manetti D, Martelli C, Romanelli MN, Scapecchi S, Salerno M, Menif H, Bello I, Mini E, Teodori E.SourceDipartimento di Scienze Farmaceutiche, Università di Firenze, via Ugo Schiff 6, 50019 Sesto Fiorentino, FI, Italy.
- Bioorganic & medicinal chemistry.Bioorg Med Chem.2013 Jan 15;21(2):456-65. doi: 10.1016/j.bmc.2012.11.019. Epub 2012 Nov 24.
- As a continuation of previous research on a new series of potent and efficacious P-gp-dependent multidrug resistant (MDR) reversers with a N,N-bis(cyclohexanol)amine scaffold, we have designed and synthesized several analogs by modulation of the two aromatic moieties linked through ester functions t
- PMID 23245571
Japanese Journal
- 腎盂尿管癌術後,ピラルビシン膀胱注入療法による術後膀胱内再発予防効果の検討
- 長島 政純,荒木 あずみ,柳澤 昌宏 [他],小宮 敦,高野 哲三,村上 貴之,池田 伊知郎
- 泌尿器科紀要 = Acta urologica Japonica 59(4), 213-216, 2013-04
- … We retrospectively evaluated 23 patients who had been administered pirarubicin by intravesical instillation once weekly for 5 weeks, after undergoing surgery for upper urinary tract cancer between May 2003 and October 2008. … We compared their clinical records with those of 19 patients with upper urinary tract cancer subjected to nephroureterectomy between 1998 and 2008, and who did not receive intravesical instillation of pirarubicin. …
- NAID 120005244621
- 中澤 成晃,今村 亮一,林 拓自 [他],山本 致之,谷川 剛,藤田 和利,細見 昌弘,伏見 博彰,山口 誓司
- 泌尿器科紀要 = Acta urologica Japonica 59(2), 117-120, 2013-02
- … Cystoscopy findings revealed multiple bladder tumors, and transurethral resection of bladder tumor (TUR-BT) followed by intravesical instillation of pirarubicin was performed. …
- NAID 120005244233
- Diffuse Large B-Cell Lymphoma with Mass Lesions of Skull Vault and Ileocecum
- Kosugi Shigeki,Kume Masaaki,Sato Joji,Sakuma Ikuo,Moroi Junta,Izumi Keiichi,Sato Yasukazu,Nakamura Naoya,Takahashi Masatomo,Miura Ikuo
- Journal of Clinical and Experimental Hematopathology 53(3), 215-219, 2013
- … She was treated by irradiation (45 Gy) of the mass on the parietal bone and with rituximab, pirarubicin, cyclophosphamide, and vincristine. …
- NAID 130003383996
Related Links
- のサプライヤーのリストを取得する Pirarubicin と同等の製品を ... Chemos GmbH ためのサプライヤです Pirarubicin. 9-(2-Carboxyphenyl)-3,6-bis(diethylamino)xanthylium chloride , aluminum saltもChemos GmbHによって処理されます。
- MedKoo Cat#: 100734 Name: Pirarubicin CAS#: 72496-41-4 Synonym: Tepirubicin; Tetrahydropyranyl-Doxorubicin; theprubicin; THP; THP-Adriamycin; THP-Doxorubicin. Foreign brand names: Pinorubicin; Theprubicine ...
Related Pictures
★リンクテーブル★
[★]
- 英
- pirarubicin
- 化
- 塩酸ピラルビシン pirarubicin hydrochloride
- 同
- THP
- 商
- テラルビシン、ピノルビン
- 関
- アントラサイクリン
- ドキソルビシンの4'-O-位にテトラヒドロピラニル基を有するアントラサイクリン系抗悪性腫瘍抗生物質。
添付文書
- テラルビシン注射用10mg/テラルビシン注射用20mg
- http://www.info.pmda.go.jp/go/pack/4235403D1042_1_03/4235403D1042_1_03?view=body
[★]